Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I)

Developing effective therapies against chronic wound healing deficiencies is a global priority. Thus we evaluated the safety of two different doses of topically administered autologous APOSEC, the secretome of apoptotic peripheral blood mononuclear cells (PBMCs), in healthy male volunteers with arti...

Descripción completa

Detalles Bibliográficos
Autores principales: Simader, Elisabeth, Traxler, Denise, Kasiri, Mohammad Mahdi, Hofbauer, Helmut, Wolzt, Michael, Glogner, Christoph, Storka, Angela, Mildner, Michael, Gouya, Ghazaleh, Geusau, Alexandra, Fuchs, Carola, Eder, Claudia, Graf, Alexandra, Schaden, Michaela, Golabi, Bahar, Aretin, Marie-Bernadette, Suessner, Susanne, Gabriel, Christian, Klepetko, Walter, Tschachler, Erwin, Ankersmit, Hendrik Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524970/
https://www.ncbi.nlm.nih.gov/pubmed/28740204
http://dx.doi.org/10.1038/s41598-017-06223-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524970/
https://www.ncbi.nlm.nih.gov/pubmed/28740204
http://dx.doi.org/10.1038/s41598-017-06223-x

Ejemplares similares